Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04340817 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Fatty Liver Disease in Nordic Countries

Study acronym: FLINC
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 13, 2020 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoint revised
    • Eligibility criteria shortened, about 3 words
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A prospective cohort study, which aims to systematically evaluate biomarkers and potential targets in NAFLD and NASH.
Trial Details
NCT Number NCT04340817
Lead Sponsor Copenhagen University Hospital, Hvidovre
Conditions
(from sponsor)		 Non-Alcoholic Fatty Liver Disease
Related terms Non-alcoholic Fatty Liver Disease
Enrollment 634 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov